Clinical Trials
3 trialsNCT03639948 2024-04-11
NeoPACT
University of Kansas Medical Center
Phase 2 Unknown
NCT03044730 2020-07-13
Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery
Northwestern University
Phase 2 Unknown
NCT01928680 2015-02-23
Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer
ChineseAMS
Phase 2 Unknown